PHASE II evaluation of dalantercept for persistent or recurrent epithelial ovarian and related cancers: An NRG oncology study Meeting Abstract
| Authors: | Burger, R. A.; Deng, W.; Makker, V.; Lankes, H. A.; Aghajanian, C.; Gray, H. J.; Wade, J. L.; Waggoner, S. E.; Levine, D. A. |
| Abstract Title: | PHASE II evaluation of dalantercept for persistent or recurrent epithelial ovarian and related cancers: An NRG oncology study |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Language: | English |
| ACCESSION: | WOS:000404711502067 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.e17050 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e17050 -- Source: Wos |
